• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Gastric mucosal prostaglandin E2 levels in cirrhosis and portal hypertension.

作者信息

Weiler H, Weiler C, Gerok W

机构信息

Department of Hepato-gastroenterology, Medical Clinic, University of Freiburg, Federal Republic of Germany.

出版信息

J Hepatol. 1990 Jul;11(1):58-64. doi: 10.1016/0168-8278(90)90272-s.

DOI:10.1016/0168-8278(90)90272-s
PMID:2398267
Abstract

Prostaglandin E2 (PGE2) tissue levels were measured, using radioimmunoassay, in specimens from the gastric antral mucosa in (a) healthy subjects, (b) patients without liver diseases in the absence or presence of gastric ulcers, and (c) patients with alcoholic cirrhosis in the absence or presence of gastric ulcers. These groups were divided further into subgroups with or without portal hypertension. PGE2 tissue levels in subjects without liver diseases were not significantly different from those of cirrhotic patients without portal hypertension. However, in cirrhotic patients with portal hypertension, the PGE2 content was significantly lower, especially in the presence of congestion in the mucosa (about 70-80%). When a gastric antral ulcer was present, a further statistically significant decrease of the PGE2 levels was observed. It was concluded that a decrease in the PGE2 tissue levels in the gastric mucosa of cirrhotic patients is related to the presence of portal hypertension. Congestion in the mucosa, as a pathogenetically relevant factor for mucosal PGE2 deficiency, may play a role.

摘要

相似文献

1
Gastric mucosal prostaglandin E2 levels in cirrhosis and portal hypertension.
J Hepatol. 1990 Jul;11(1):58-64. doi: 10.1016/0168-8278(90)90272-s.
2
Decreased prostaglandin E2 immunoactivity of gastric mucosa in portal hypertension.
Neth J Med. 1991 Feb;38(1-2):4-12.
3
Endogenous prostaglandin E2 in gastric mucosa of patients with alcoholic cirrhosis and portal hypertension.酒精性肝硬化和门静脉高压患者胃黏膜中的内源性前列腺素E2
Gastroenterology. 1987 Jul;93(1):135-40. doi: 10.1016/0016-5085(87)90325-8.
4
Protective effect of omeprazole on gastric mucosal of cirrhotic portal hypertension rats.奥美拉唑对肝硬化门静脉高压大鼠胃黏膜的保护作用
Asian Pac J Trop Med. 2014 May;7(5):402-6. doi: 10.1016/S1995-7645(14)60065-1.
5
Increased prostacyclin content in gastric mucosa of cirrhotic patients with portal hypertensive gastropathy.门静脉高压性胃病肝硬化患者胃黏膜中前列环素含量增加。
Prostaglandins Leukot Essent Fatty Acids. 1995 Jul;53(1):41-5. doi: 10.1016/0952-3278(95)90081-0.
6
Increased gastric PGE2 biosynthesis in cirrhotic patients with gastric vascular ectasia.
Am J Gastroenterol. 1990 Feb;85(2):138-44.
7
Gastric tissue oxidative changes in portal hypertension and cirrhosis.门静脉高压症和肝硬化时胃组织的氧化变化
Dig Dis Sci. 2007 May;52(5):1154-8. doi: 10.1007/s10620-006-9139-8. Epub 2007 Mar 8.
8
Gastric mucosal prostaglandin E2 levels in gastric non-ulcer and ulcer patients with chronic renal failure or without renal disease, and in healthy subjects.
Neth J Med. 1990 Dec;37(5-6):189-96.
9
Gastric and colonic inflammatory and vasoactive mediators in experimental portal hypertension.实验性门静脉高压症中的胃和结肠炎症及血管活性介质
Liver. 1996 Feb;16(1):12-8. doi: 10.1111/j.1600-0676.1996.tb00697.x.
10
PGE /EP receptor attenuated mucosal injury via β-arrestin1/Src/EGFR-mediated proliferation in portal hypertensive gastropathy.前列腺素E/前列腺素E受体通过β-抑制蛋白1/肉瘤病毒癌基因/表皮生长因子受体介导的增殖减轻门静脉高压性胃病中的黏膜损伤。
Br J Pharmacol. 2017 May;174(9):848-866. doi: 10.1111/bph.13752. Epub 2017 Mar 25.

引用本文的文献

1
Upper Gastrointestinal Endoscopic Findings and Their Clinical Correlates in Patients With Liver Cirrhosis in Northern Ghana.加纳北部肝硬化患者的上消化道内镜检查结果及其临床关联
Cureus. 2024 Aug 25;16(8):e67725. doi: 10.7759/cureus.67725. eCollection 2024 Aug.
2
Role of ascitic prostaglandin E2 in diagnosis of spontaneous bacterial peritonitis and prediction of in-hospital mortality in patients with decompensated cirrhosis.腹水前列腺素E2在失代偿期肝硬化患者自发性细菌性腹膜炎诊断及院内死亡预测中的作用
Medicine (Baltimore). 2019 Jun;98(26):e16016. doi: 10.1097/MD.0000000000016016.
3
The recurrent bleeding risk of a Forrest IIc lesion at the second-look endoscopy can be indicated by high Rockall scores ≥ 6.
在第二次内镜检查时,Forrest IIc病变的再出血风险可通过≥6分的高Rockall评分来表明。
Surg Endosc. 2020 Apr;34(4):1592-1601. doi: 10.1007/s00464-019-06919-3. Epub 2019 Jun 20.
4
Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.门静脉高压性胃病:病理生理学、临床表现、自然史及治疗的系统评价
World J Hepatol. 2016 Feb 8;8(4):231-62. doi: 10.4254/wjh.v8.i4.231.
5
Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome.门静脉高压性胃病和胃窦血管扩张(GAVE)综合征。
Gut. 2001 Dec;49(6):866-72. doi: 10.1136/gut.49.6.866.
6
Cytoprotective activity in the gastric mucosa of rats exposed to carbon tetrachloride-induced liver injury.四氯化碳诱导肝损伤大鼠胃黏膜的细胞保护活性。
Inflammation. 1997 Oct;21(5):475-88. doi: 10.1023/a:1027355528929.
7
Prostaglandin E2 and prostaglandin F2 alpha biosynthesis in human gastric mucosa: effect of chronic alcohol misuse.前列腺素E2和前列腺素F2α在人胃黏膜中的生物合成:长期酗酒的影响
Gut. 1996 Sep;39(3):348-52. doi: 10.1136/gut.39.3.348.
8
Peptic ulcer surgery in patients with liver cirrhosis.肝硬化患者的消化性溃疡手术
Ann Surg. 1993 Apr;217(4):338-46. doi: 10.1097/00000658-199304000-00005.
9
Maintenance of intragastric pH > 4 with famotidine in duodenal ulcer patients: factors influencing drug requirements.十二指肠溃疡患者使用法莫替丁维持胃内pH值>4:影响药物需求量的因素
Gut. 1994 Jun;35(6):750-4. doi: 10.1136/gut.35.6.750.
10
Gastric mucosal PGE2 levels in gastric non-ulcer and ulcer patients with chronic renal failure or without renal diseases and in healthy subjects.
Dig Dis Sci. 1990 Dec;35(12):1488-93. doi: 10.1007/BF01540566.